0131-1810Level 3
Vimpat (lacosamide)
**Product type:** Human Prescription Drug
**Active ingredient:** LACOSAMIDE
**Strength:** 10 mg/mL
**Dosage form:** Injection
**Route:** Intravenous
**Labeler:** UCB, Inc.
**Marketing category:** NDA (NDA022254)
**Pharmacologic class:** Decreased Central Nervous System Disorganized Electrical Activity [PE]
**DEA schedule:** CV
GET
/api/v1/systems/ndc_fda/nodes/0131-1810Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.